Friday, April 2, 2021
Home Health & Fitness "The acceleration is strong", according to Stanislas Niox-Chateau, president of Doctolib
- Advertisement -

“The acceleration is strong”, according to Stanislas Niox-Chateau, president of Doctolib


Stanislas Niox-Chateau, President of Doctolib, invited to franceinfo on Friday March 26. (FRANCEINFO / RADIOFRANCE)

The vaccination campaign against the Covid-19 coronavirus is accelerating. After weeks of shortage, where finding an appointment was sometimes impossible, the situation is improving markedly, according to Stanislas Niox-Chateau, the president of Doctolib, invited to franceinfo on Friday March 26. Doctolib is one of the three platforms selected by the State to organize these meetings. “IThere has been a strong acceleration for three weeks now “, explains Stanislas Niox-Chateau.

This week, 85% more appointments were made, compared to last week. And yesterday, we reached a record, with 450,000 appointments made on Doctolib.

Stanislas Niox Chateau, President of Doctolib

In some regions, the situation remains tense. It just depends on the vaccine doses available, explains the founder of Doctolib. The centers are ready, appointment scheduling is working. According to him, nine million vaccination appointments have been made on the platform.

Do the French continue to treat themselves, despite the rebound of the epidemic? Yes, according to Stanislas Niox-Château, for whom the situation has nothing to do with that of last year, during the first confinement. The number of visits then collapsed. This is no longer the case, notes the manager. The French continue to treat themselves normally in town. At the hospital, there are deprogramming as the Minister of Health announced. “

Has the pandemic accelerated the success of Doctolib? Non, according to the founder of the platform. We are exactly in our plans. Growth had no impact on our growth (…) To be honest, we will not earn a euro on the vaccination campaign. “

- Advertisement -



Source site www.francetvinfo.fr

- Advertisement -
- Advertisement -
- Advertisement -
RELATED ARTICLES
- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments

- Advertisement -